Late phase research has changed substantially over the past decade. During this period of innovation and development, many myths and misconceptions about late phase research have surfaced regarding study design, outsourcing, preferred provider access, and scientific value, just to name a few. Throughout this series, a panel of post-marketing experts with diverse backgrounds in late phase research will define and disprove these myths. Join PRA Health Sciences' Maria Harrison, Vice President of Late Phase Services, in an introduction to our 10-part podcast series "Dispelling Late Phase Myths and Misconceptions" as she discusses the rationale behind these myths as well as the content that will be covered in upcoming podcasts.
Advocacy Groups in Patient-Focused Drug Development
Meeting Enrollment Goals Breast Cancer
An open-label, randomized, multi-center study to evaluate the use of Study Drug in the prevention of cancer treatment-related bone loss in…